출판 : MarketsandMarkets（마켓츠앤마켓츠）출판년월 : 2022년06월
핵산(Nucleic Acid) 분리 및 정제 시장 : 제품 (키트, 시약, 장비), 방법 (컬럼, 자기 비드), 유형 (게놈 DNA, 플라스미드 DNA, miRNA), 용도 (창약, 진단), 최종 사용자 (제약, 생명 공학) – 2027 년까지 세계 예측
Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027
| 페이지수 | 230 |
| 도표수 | 209 |
| 구성 | 영문조사보고서 |
| 가격 |
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation.
전 세계 핵산 분리 및 정제 시장은 예측 기간 동안 CAGR 7.9%로 2022년 63억 달러에서 2027년 92억 달러에 이를 것으로 예상됩니다. 이 시장의 성장은 주로 R&D 활동 증가와 기술 발전 및 자동화 증가에 기인합니다.
The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market.
As the world becomes more connected, collaboration and cooperation are needed to reduce the impact of future epidemics. To reduce the risk of future epidemics, increasing research is being conducted across the globe. For instance, the National Institutes of Health (US) invests USD 40 billion annually in health innovation and is expected to spend billions more on COVID- 19 research. Similarly, the UK government has decided to increase its R&D spending over the next three years to reach USD 28.82 billion (GBP 22 billion) by 2024–25. Countries in Asia, such as China and India, have also increased investments in their healthcare and pharmaceutical sectors.
“The instruments segment will grow at the highest rate during the forecast period.”
On the basis ofproduct, the nucleic acid isolation and purification market is segmented intokits, reagents, and instruments. In 2021, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.
“By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.”
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation andpurification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
“The market in the Asia Pacificis projected to witness the highest growth rate during the forecast period (2020–2027).”
North America accounted for the largest share of the nucleic acid isolation and purification market in 2021. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacificis projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1(29%), Tier 2(37%), and Tier 3(34%)
• By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals& Diagnostic Centers (30%), and Academic &Government Research Institutes (22%), and Other End Users (10%)
• By Designation: C-level(37%), Director-level(23%), and Managers(40%)
• By Region: North America(37%), Europe(30%), Asia Pacific(21%), and the RoW(12%)
QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GEHealthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
Research Coverage:
The report analyzes the nucleic acid isolation and purification market and aims at estimating themarket size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one, or a combination of the belowmentioned five strategies.
This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutionsacross regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 33)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC (2021)
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 LIMITATIONS FOR RESEARCH
3 EXECUTIVE SUMMARY (Page No. – 42)
FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2022 VS. 2027 (USD MILLION)
FIGURE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
4 PREMIUM INSIGHTS (Page No. – 48)
4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2021)
FIGURE 15 KITS TO DOMINATE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2021
4.3 GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
FIGURE 16 JAPAN TO WITNESS HIGHEST MARKET GROWTH RATE FROM 2022 TO 2027
4.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
FIGURE 17 NORTH AMERICA TO DOMINATE MARKET IN 2027
4.5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE IN FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 53)
5.1 MARKET DYNAMICS
FIGURE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.1.1 DRIVERS
5.1.1.1 Increasing R&D activities
5.1.1.2 Technological advancements and increasing automation
5.1.2 RESTRAINTS
5.1.2.1 High cost of automated instruments
5.1.3 OPPORTUNITIES
5.1.3.1 High scope of growth in emerging economies
5.1.3.2 Improving regulatory and reimbursement scenario
5.1.3.3 Molecular diagnostics and personalized medicine
5.1.4 TRENDS
5.1.4.1 Increase in government funding
5.2 COVID-19 IMPACT ON THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 1 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT FROM NEW ENTRANTS
5.3.2 THREAT FROM SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 DEGREE OF COMPETITION
5.4 TECHNOLOGY ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 20 SUPPLY CHAIN ANALYSIS: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE (Page No. – 62)
6.1 INTRODUCTION
TABLE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2022–2027 (USD MILLION)
6.2 PLASMID DNA ISOLATION AND PURIFICATION
6.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
TABLE 4 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 5 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
6.3 TOTAL RNA ISOLATION AND PURIFICATION
6.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH
TABLE 6 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 7 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
6.4 GENOMIC DNA ISOLATION AND PURIFICATION
6.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS
TABLE 8 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 9 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
6.5 MESSENGER RNA ISOLATION AND PURIFICATION
6.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS
TABLE 10 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 11 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
6.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
6.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
TABLE 12 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 13 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
6.7 MICRORNA ISOLATION AND PURIFICATION
6.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES
TABLE 14 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 15 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
6.8 PCR CLEANUP
6.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
TABLE 16 PCR CLEANUP MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 17 PCR CLEANUP MARKET, BY REGION, 2022–2027 (USD MILLION)
6.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES
TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 19 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2022–2027 (USD MILLION)
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD (Page No. – 77)
7.1 INTRODUCTION
TABLE 20 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 21 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2022–2027 (USD MILLION)
7.2 COLUMN-BASED ISOLATION AND PURIFICATION
7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION IS LARGEST SEGMENT OF MARKET
TABLE 22 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 23 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
TABLE 24 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 25 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
7.4 REAGENT-BASED ISOLATION AND PURIFICATION
7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH BETWEEN 2022 AND 2027
TABLE 26 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 27 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2022–2027 (USD MILLION)
7.5 OTHER ISOLATION AND PURIFICATION METHODS
TABLE 28 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2019–2025 (USD MILLION)
TABLE 29 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2022–2027 (USD MILLION)
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (Page No. – 84)
8.1 INTRODUCTION
TABLE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2019–2021 (USD MILLION)
TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2022–2027 (USD MILLION)
8.2 KITS
8.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2021
TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 33 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2022–2027 (USD MILLION)
8.3 REAGENTS
8.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
TABLE 34 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 35 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
8.4 INSTRUMENTS
8.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS
TABLE 36 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 37 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2022–2027 (USD MILLION)
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION (Page No. – 91)
9.1 INTRODUCTION
TABLE 38 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2019–2021 (USD MILLION)
TABLE 39 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
9.2 DIAGNOSTICS
9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET
TABLE 40 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019–2021 (USD MILLION)
TABLE 41 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2027 (USD MILLION)
9.3 DRUG DISCOVERY & DEVELOPMENT
9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS
TABLE 42 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019–2021 (USD MILLION)
TABLE 43 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2027 (USD MILLION)
9.4 PERSONALIZED MEDICINE
9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE SEGMENT GROWTH
TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2019–2021 (USD MILLION)
TABLE 45 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2022–2027 (USD MILLION)
9.5 AGRICULTURE & ANIMAL RESEARCH
9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
TABLE 46 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2019–2021 (USD MILLION)
TABLE 47 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022–2027 (USD MILLION)
9.6 OTHER APPLICATIONS
TABLE 48 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2021 (USD MILLION)
TABLE 49 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2027 (USD MILLION)
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER (Page No. – 101)
10.1 INTRODUCTION
TABLE 50 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2019–2021 (USD MILLION)
TABLE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2022–2027 (USD MILLION)
10.2 HOSPITALS & DIAGNOSTIC CENTERS
10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
TABLE 52 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2019–2021 (USD MILLION)
TABLE 53 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2027 (USD MILLION)
10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
TABLE 54 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2019–2021 (USD MILLION)
TABLE 55 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022–2027 (USD MILLION)
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
TABLE 56 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2021 (USD MILLION)
TABLE 57 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2027 (USD MILLION)
10.5 CONTRACT RESEARCH ORGANIZATIONS
10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
TABLE 58 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019–2021 (USD MILLION)
TABLE 59 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2027 (USD MILLION)
10.6 OTHER END USERS
TABLE 60 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2019–2021 (USD MILLION)
TABLE 61 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2022–2027 (USD MILLION)
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION (Page No. – 110)
11.1 INTRODUCTION
TABLE 62 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2020–2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
TABLE 63 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 64 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.1 US
11.2.1.1 Government and private funding to support market growth
TABLE 69 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 71 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing investments in genomics to boost market demand
TABLE 74 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 76 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3 EUROPE
TABLE 79 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 82 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany to dominate market in Europe
TABLE 85 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027
TABLE 86 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 87 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 90 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.2 UK
11.3.2.1 Government support for research through investments, funds, and grants to support market growth
TABLE 91 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 92 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 93 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 95 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High cancer burden to drive market growth
TABLE 96 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 97 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 98 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 100 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.4 REST OF EUROPE
TABLE 101 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 102 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
TABLE 103 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 104 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 105 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 106 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.1 CHINA
11.4.1.1 China is expected to register the highest growth in the nucleic acid isolation and purification market in the APAC
TABLE 109 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 110 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 111 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 113 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Various conferences & workshops are organized to explore various NAIP applications; a key factor driving market growth
TABLE 114 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 116 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 118 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Focused initiatives in the pharmaceutical & biotechnology industries to drive the market growth for NAIP in India
TABLE 119 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 120 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 121 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 123 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 124 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 125 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 126 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 128 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5 REST OF THE WORLD
TABLE 129 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 130 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 131 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 132 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.1 LATIN AMERICA
11.5.1.1 Increasing cancer cases to drive the demand for cancer diagnostic tests and, in turn, drive market growth for NAIP
TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 136 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 137 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.2 MIDDLE EAST & AFRICA
11.5.2.1 Lack of research infrastructure to restrict the growth of the NAIP market in this region
TABLE 140 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 145 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 147 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. – 160)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 23 KEY DEVELOPMENTS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019-2022
12.3 MARKET SHARE ANALYSIS
FIGURE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 148 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION
12.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 25 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019–2021
12.5 COMPANY EVALUATION QUADRANT
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT, 2021
12.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
12.7 COMPANY FOOTPRINT ANALYSIS
12.7.1 COMPANY PRODUCT FOOTPRINT
TABLE 149 COMPANY PRODUCT FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021)
12.8 COMPANY REGIONAL FOOTPRINT
TABLE 150 COMPANY REGIONAL FOOTPRINT: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2021)
12.9 COMPETITIVE SCENARIO
TABLE 151 PRODUCT LAUNCHES
TABLE 152 DEALS
TABLE 153 OTHER DEVELOPMENTS
13 COMPANY PROFILES (Page No. – 171)
13.1 MAJOR PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 154 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 28 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
13.1.2 MERCK KGAA
TABLE 155 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 29 MERCK KGAA: COMPANY SNAPSHOT (2021)
13.1.3 QIAGEN
TABLE 156 QIAGEN: BUSINESS OVERVIEW
FIGURE 30 QIAGEN: COMPANY SNAPSHOT (2021)
13.1.4 F. HOFFMANN-LA ROCHE AG
TABLE 157 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
FIGURE 31 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021)
13.1.5 GENERAL ELECTRIC COMPANY
TABLE 158 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
FIGURE 32 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
13.1.6 PROMEGA CORPORATION
TABLE 159 PROMEGA CORPORATION: BUSINESS OVERVIEW
13.1.7 AGILENT TECHNOLOGIES, INC.
TABLE 160 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
13.1.8 DANAHER CORPORATION
TABLE 161 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
13.1.9 BIO-RAD LABORATORIES, INC.
TABLE 162 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
13.1.10 ILLUMINA, INC.
TABLE 163 ILLUMINA, INC.: BUSINESS OVERVIEW
FIGURE 36 ILLUMINA, INC.: COMPANY SNAPSHOT (2021)
13.1.11 TAKARA BIO, INC.
TABLE 164 TAKARA BIO, INC.: BUSINESS OVERVIEW
13.1.12 NEW ENGLAND BIOLABS
TABLE 165 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
13.1.13 OMEGA BIO-TEK, INC.
TABLE 166 OMEGA BIO-TEK, INC.: BUSINESS OVERVIEW
13.1.14 NORGEN BIOTEK
TABLE 167 NORGEN BIOTEK: BUSINESS OVERVIEW
13.1.15 ZYMO RESEARCH
TABLE 168 ZYMO RESEARCH: BUSINESS OVERVIEW
13.2 OTHER COMPANIES
13.2.1 GENAXXON BIOSCIENCE GMBH
TABLE 169 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
13.2.2 3D BLACKBIO BIOTECH INDIA LTD.
TABLE 170 3D BLACKBIO BIOTECH INDIA LTD.: COMPANY OVERVIEW
13.2.3 INVITEK MOLECULAR GMBH
TABLE 171 INVITEK MOLECULAR GMBH: COMPANY OVERVIEW
13.2.4 BIOVISION
TABLE 172 BIOVISION: COMPANY OVERVIEW
13.2.5 ANALYTIK JENA AG
TABLE 173 ANALYTIK JENA AG: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX (Page No. – 230)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
